Brian Luque
Keine laufenden Positionen mehr
Profil
Brian Luque worked as a Director of Investor Relations at Invivo Therapeutics Holdings Corp.
and LogicBio Therapeutics, Inc.
Ehemalige bekannte Positionen von Brian Luque
| Unternehmen | Position | Ende |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Investor Relations Kontakt | - |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
